Surgical antibiotic prophylaxis: is the clinical practice based on evidence?


Journal

Einstein (Sao Paulo, Brazil)
ISSN: 2317-6385
Titre abrégé: Einstein (Sao Paulo)
Pays: Brazil
ID NLM: 101281800

Informations de publication

Date de publication:
2020
Historique:
received: 30 09 2019
accepted: 13 04 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 13 1 2021
Statut: epublish

Résumé

To assess the surgical antibiotic prophylaxis. This was a descriptive study performed at a public tertiary care university hospital gathering prescription, sociodemographic and hospitalization data of inpatients admitted in 2014 who used antimicrobial drugs. This data were obtained from the hospital electronic database. The antimicrobial data were classified according to the anatomical, therapeutic chemical/defined daily dose per 1,000 inpatients. An exploratory analysis was performed using principal component analysis. A total of 5,182 inpatients were prescribed surgical antibiotic prophylaxis. Of the total antimicrobial use, 11.7% were for surgical antibiotic prophylaxis. The orthopedic, thoracic and cardiovascular postoperative units, and postoperative intensive care unit comprised more than half of the total surgical antibiotic prophylaxis use (56.3%). The duration of antimicrobial use of these units were 2.2, 2.0, and 1.4 days, respectively. Third-generation cephalosporins and fluoroquinolones had the longest use among antimicrobial classes. Surgical antibiotic prophylaxis was inadequate in the orthopedic, postoperative intensive care, thoracic and cardiovascular postoperative, gynecology and obstetrics, and otolaryngology units. Therefore, the development and implementation of additional strategies to promote surgical antibiotic stewardship at hospitals are essential.

Identifiants

pubmed: 33237245
pii: S1679-45082020000100281
doi: 10.31744/einstein_journal/2020AO5427
pmc: PMC7664826
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng por

Sous-ensembles de citation

IM

Pagination

eAO5427

Références

Infection. 2010 Feb;38(1):19-24
pubmed: 19904488
Antimicrob Agents Chemother. 2011 Oct;55(10):4659-63
pubmed: 21825293
J Formos Med Assoc. 2011 Oct;110(10):619-26
pubmed: 21982465
Surgery. 1961 Jul;50:161-8
pubmed: 16722001
Braz J Infect Dis. 2005 Aug;9(4):283-7
pubmed: 16270119
Acta Obstet Gynecol Scand. 2005 Apr;84(4):384-9
pubmed: 15762971
J Thorac Cardiovasc Surg. 2008 Dec;136(6):1522-7
pubmed: 19114201
Gynecol Oncol. 1989 Oct;35(1):55-60
pubmed: 2792903
J Laryngol Otol. 2015 Jan;129(1):63-7
pubmed: 25592303
Infect Control Hosp Epidemiol. 2014 Jun;35(6):605-27
pubmed: 24799638
Lancet. 2003 Jun 14;361(9374):2068-77
pubmed: 12814731
J Laryngol Otol. 2008 Apr;122(4):403-8
pubmed: 17445309
Acta Obstet Gynecol Scand. 2015 Jan;94(1):43-9
pubmed: 25263498
Am J Surg. 2005 Apr;189(4):395-404
pubmed: 15820449
J Antimicrob Chemother. 2009 Dec;64(6):1307-15
pubmed: 19837713
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):771-4
pubmed: 12874080
Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S621-5
pubmed: 2068470
Am J Infect Control. 2017 Oct 1;45(10):1111-1115
pubmed: 28629754
J Manag Care Pharm. 2009 Apr;15(3):262-71
pubmed: 19326957
Ann Thorac Surg. 2006 Jan;81(1):397-404
pubmed: 16368422
Clin Infect Dis. 2007 Apr 1;44(7):921-7
pubmed: 17342642
Br J Exp Pathol. 1957 Feb;38(1):79-96
pubmed: 13413084
J Thorac Cardiovasc Surg. 1997 Aug;114(2):162-8
pubmed: 9270631
Can J Surg. 1990 Apr;33(2):122-7
pubmed: 2268811

Auteurs

Lucas Borges Pereira (LB)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Cinara Silva Feliciano (CS)

Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Diego Silva Siqueira (DS)

Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista "Júlio de Mesquita Filho", Araraquara, SP, Brazil.

Fernando Bellissimo-Rodrigues (F)

Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Leonardo Régis Leira Pereira (LRL)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH